Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Wang D et al. | 2018 | intact cell/cell culture, human cancer cell lines (HeLa, HCT116, MCF7, A549, and GIST-T1), rat cancer cell lines (differentiated PC12, undifferentiated PC12, and C6), non-cancer cell lines (RPE1, CHO, and 293T) | 50/60 Hz, static magnetic field, magnetic field | - |
| Aldinucci C et al. | 2003 | intact cell/cell culture, Jurkat cells (human lymphoblastoid T cells) and human lymphocytes | RF, static magnetic field, MRI | 0.7 mT–4.75 T |
| Teichmann EM et al. | 2000 | bacterium, <i>Salmonella typhimurium</i> (TA98, TA100, TA102, TA1535, TA1537, wild type RTA) | RF, static magnetic field, MRI, co-exposure | 5.8 µT–7.2 T |
| Vale P | 2020 | intact cell/cell culture, dinoflagellates (<i>Alexandrium pacificum</i> and <i>Gymnodinium cacenatum</i>) | geomagnetic field, magnetic field, low frequency, signals/pulses, co-exposure | - |
| Fu JP et al. | 2016 | intact cell/cell culture, skeletal muscle cells (mouse) | geomagnetic field, shielding/field deprivation | - |
| Mo WC et al. | 2016 | - | geomagnetic field, shielding/field deprivation | - |
| Xue Y et al. | 2020 | animal, mouse/C57BL/6 | geomagnetic field, shielding/field deprivation | - |
| Wang GM et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | geomagnetic field, shielding/field deprivation | - |
| Lange S et al. | 2024 | intact cell/cell culture, PC3 cells (human prostate cancer cell line) and PNT2 cells (prostate epithelial cell line) | geomagnetic field, shielding/field deprivation | - |
| Jandova A et al. | 2005 | isolated antigens in T cell suspensions | magnetic field, 50/60 Hz, DC, static magnetic field | 0.05–0.1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
